PARADIGM DX IGG/IGM COVID-19 ANTIBODIES
LIVE

Serial Number

90028323

Owner

Integrity Laboratories, LLC

Attorney

Michael E. Robinson

First Use Date

Jun 11, 2020

Filing Date

Jun 30, 2020

Add to watchlist:

No watchlists yet
View on USPTO

PARADIGM DX IGG/IGM COVID-19 ANTIBODIES Trademark

Serial Number: 90028323 • Registration: 6359980

PARADIGM DX IGG/IGM COVID-19 ANTIBODIES is a trademark filed by Integrity Laboratories, LLC on June 30, 2020. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Integrity Laboratories, LLC (16 trademarks)

Knoxville, TN 37932

Entity Type: 16

Trademark Details

Filing Date

June 30, 2020

Registration Date

May 25, 2021

First Use Anywhere

June 11, 2020

First Use in Commerce

June 11, 2020

Published for Opposition

March 9, 2021

Goods & Services

Medical laboratory services, namely, testing for COVID-19 antibodies

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 25, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
May 25, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 9, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 9, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 17, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 3, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 3, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 3, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 3, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 3, 2021 CNEA
ASSIGNED TO EXAMINER
Jan 22, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 30, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2020 NWOS
NEW APPLICATION ENTERED
Jul 3, 2020 NWAP